In a collaborative effort, TED and TRACK-TBI Investigators drafted two responses to the FDA's Request for Information on Identifying Potential Biomarkers for Qualification and Describing Contexts of Use to Address Areas Important to Drug Development. Responses on the potential of blood-based and MRI biomarkers in TBI were submitted.

To read the response on Blood-Based Biomarkers, click here.

To read the response on MRI Biomarkers, click here